{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T18:11:01Z","timestamp":1768068661972,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1002\/jps.20334","type":"journal-article","created":{"date-parts":[[2005,5,26]],"date-time":"2005-05-26T22:48:55Z","timestamp":1117147735000},"page":"1577-1588","source":"Crossref","is-referenced-by-count":27,"title":["Microdialysis evaluation of the brain distribution of stavudine following intranasal and intravenous administration to rats"],"prefix":"10.1016","volume":"94","author":[{"given":"Zheng","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanfa","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald J.","family":"Sawchuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.20334_bb0010","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/10611869808997870","article-title":"Nasal route for direct delivery of solutes to the central nervous system: Fact or fiction?","volume":"5","author":"Mathison","year":"1998","journal-title":"J Drug Target"},{"key":"10.1002\/jps.20334_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0928-0987(00)00087-7","article-title":"Transport of drugs from the nasal cavity to the central nervous system","volume":"11","author":"Illum","year":"2000","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.20334_bb0020","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2165\/00003088-200140120-00003","article-title":"Delivery of neurotrophic factors to the central nervous system","volume":"40","author":"Throne","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1002\/jps.20334_bb0025","first-page":"46","article-title":"Intranasal delivery: Bypassing the blood\u2013brain barrier to deliver therapeutic agents to the brain and spinal cord","volume":"2","author":"Frey","year":"2002","journal-title":"Drug Deliv Tech"},{"key":"10.1002\/jps.20334_bb0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/10717549709051878","article-title":"Delivery of 125I-NGF to the brain via the olfactory route","volume":"4","author":"Frey","year":"1997","journal-title":"Drug Deliv"},{"key":"10.1002\/jps.20334_bb0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JAD-1998-1102","article-title":"Delivery of nerve growth factor to the brain via the olfactory pathway","volume":"1","author":"Chen","year":"1998","journal-title":"J Alzheimer Dis"},{"key":"10.1002\/jps.20334_bb0040","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0006-3223(95)00180-8","article-title":"Brain potential changes after intranasal vs. intravenous administration of vasopressin: Evidence for a direct nose\u2013brain pathway for peptide effects in humans","volume":"39","author":"Pietrowsky","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1002\/jps.20334_bb0045","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0306-4530(96)00012-1","article-title":"A nose\u2013brain pathway for psychotropic peptides: Evidence from a brain evoked potential study with cholecystokinin","volume":"21","author":"Pietrowsky","year":"1996","journal-title":"Psychoneuroendocinol"},{"key":"10.1002\/jps.20334_bb0050","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2337\/diabetes.48.3.557","article-title":"Central nervous system effects of intranasally administered insulin during euglycemia in man","volume":"48","author":"Kern","year":"1999","journal-title":"Diabetes"},{"key":"10.1002\/jps.20334_bb0055","series-title":"Acute intranasal insulin administration improves verbal memory for adults with Alzheimer's disease","author":"Baker","year":"2003"},{"key":"10.1002\/jps.20334_bb0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-510X(01)00532-9","article-title":"Intranasal administration of insulin-like growth factor-1 bypasses the blood\u2013brain barrier and protects against focal cerebral ischemic damage","volume":"187","author":"Liu","year":"2001","journal-title":"J Neuro Sci"},{"key":"10.1002\/jps.20334_bb0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3940(01)01982-6","article-title":"Non-invasive intranasal insulin-like growth factor-1 reduces infarct volume and improves neurologic function in rats following middle cerebral ischemic damage","volume":"308","author":"Liu","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1002\/jps.20334_bb0070","first-page":"435","article-title":"Uptake of radioactivity by body fluids and tissues in rhesus monkeys after intravenous injection or intranasal spray of tritium-labelled oestradiol and progesterone","volume":"43","author":"Anand Kumar","year":"1974","journal-title":"Curr Sci"},{"key":"10.1002\/jps.20334_bb0075","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.2042-7158.1991.tb03510.x","article-title":"Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity","volume":"43","author":"Sakane","year":"1991","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.20334_bb0080","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1248\/bpb.17.1135","article-title":"Nasal absorption of Zidovudine and its transport to cerebrospinal fluid in rats","volume":"17","author":"Seki","year":"1994","journal-title":"Biol Pharm Bull"},{"key":"10.1002\/jps.20334_bb0085","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1248\/bpb.21.272","article-title":"Direct transport of 2\u2032,3\u2032-didehydro-3\u2032-deoxythymidine (d4T) and its ester derivatives to the cerebrospinal fluid via the nasal mucous membrane in rats","volume":"21","author":"Yajima","year":"1998","journal-title":"Biol Pharm Bull"},{"key":"10.1002\/jps.20334_bb0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0378-5173(98)00170-7","article-title":"Lidocaine distribution into the CNS following nasal and arterial delivery: A comparison of local sampling and microdialysis techniques","volume":"171","author":"Chou","year":"1998","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.20334_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(03)00341-7","article-title":"Profiles of methotrexate in blood and CSF following intranasal and intravenous administration to rats","volume":"263","author":"Wang","year":"2003","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.20334_bb0100","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1021\/js9900295","article-title":"Direct transport of cocaine from the nasal cavity to the brain following intranasal cocaine administration in rats","volume":"88","author":"Chow","year":"1999","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20334_bb0105","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/jps.1122","article-title":"Direct nose\u2013brain transport of benzoylecgonine following intranasal administration in rats","volume":"90","author":"Chow","year":"2001","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20334_bb0110","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/(SICI)1099-081X(199812)19:9<571::AID-BDD142>3.0.CO;2-O","article-title":"Brain uptake of dihydroergotamine after intravenous and nasal administration in the rat","volume":"19","author":"Wang","year":"1998","journal-title":"Biopharm Drug Dispos"},{"key":"10.1002\/jps.20334_bb0115","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijpharm.2003.09.017","article-title":"A microdialysis model to examine nasal drug delivery and olfactory absorption in rats using lidocaine hydrochloride as a model drug","volume":"269","author":"Bagger","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.20334_bb0120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejps.2003.10.012","article-title":"The potential of nasal application for delivery to the central brain\u2014A microdialysis study of fluorescein in rats","volume":"21","author":"Bagger","year":"2004","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.20334_bb0125","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1023\/A:1012191515035","article-title":"Microdialysis studies of the distribution of stavudine into the central nervous system in the freely-moving rat","volume":"14","author":"Yang","year":"1997","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20334_bb0130","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1023\/A:1018921906993","article-title":"Investigation of the distribution of EAB 515 to cortical ECF and CSF in freely-moving rats utilizing microdialysis","volume":"11","author":"Malhotra","year":"1994","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20334_bb0135","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0378-5173(81)90058-2","article-title":"Absorption of drugs from the nasal mucosa of rat","volume":"7","author":"Hirai","year":"1981","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.20334_bb0140","series-title":"Drug permeation enhancement: Theory and applications","first-page":"345","article-title":"Toxicological evaluation of intranasal peptide and protein drugs","author":"Dorato","year":"1994"},{"key":"10.1002\/jps.20334_bb0145","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1023\/A:1015808808115","article-title":"High performance liquid chromatographic determination of 2\u2032,3\u2032-didehydro-3\u2032-deoxythymidine (d4T) in human and rabbit plasma and urine and its application to pharmacokinetic studies in the rabbit","volume":"8","author":"Wong","year":"1991","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20334_bb0150","first-page":"907","article-title":"Pharmacokinetics of 3\u2032-fluoro-3\u2032-deoxythymidine and 3\u2032-deoxy-2\u2032,3\u2032-didehydrothymidine in rats","volume":"31","author":"Boudinot","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.20334_bb0155","first-page":"1","article-title":"Toxicokinetics of 2\u2032,3\u2032-didehydro-3\u2032-deoxythymidine, stavudine (d4T)","volume":"27","author":"Kaul","year":"1999","journal-title":"Drug Metab and Diso"},{"key":"10.1002\/jps.20334_bb0160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1023\/A:1011015316327","article-title":"Probe calibration in transient microdialysis in vivo","volume":"18","author":"Bungay","year":"2001","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20334_bb0165","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1124\/jpet.301.3.1003","article-title":"Zidovudine concentration in brain extracellular fluid measured by microdialysis: Steady-state and transient results in rhesus monkey","volume":"301","author":"Fox","year":"2002","journal-title":"J Pharm Exp Ther"},{"key":"10.1002\/jps.20334_bb0170","first-page":"213","article-title":"The relevance to humans of animal models for inhalation studies of cancer in the nose and upper airways","volume":"2","author":"DeSesso","year":"1993","journal-title":"Qual Assur: Good Practice, Regulation, and Law"},{"key":"10.1002\/jps.20334_bb0175","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1248\/cpb.39.2456","article-title":"The transport of a drug to the cerebrospinal fluid directly from the nasal cavity: The relation to the lipophilicity of the drug","volume":"39","author":"Sakane","year":"1991","journal-title":"Chem Pharm Bull"},{"key":"10.1002\/jps.20334_bb0180","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.2042-7158.1995.tb05814.x","article-title":"Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: The relation to the molecular weight of drugs","volume":"47","author":"Sakane","year":"1995","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.20334_bb0185","series-title":"Peptide drug delivery to the brain","first-page":"99","author":"Pardridge","year":"1991"},{"key":"10.1002\/jps.20334_bb0190","author":"Chen","year":"2000"},{"key":"10.1002\/jps.20334_bb0195","first-page":"1","article-title":"The brain and the lymphatic system (I)","volume":"29","author":"Fodi","year":"1996","journal-title":"Lymphology"},{"key":"10.1002\/jps.20334_bb0200","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1023\/A:1015827917684","article-title":"Drug metabolism and laboratory anesthetic protocols in the rat: Examination of antipyrine pharmacokinetics","volume":"8","author":"Gumbleton","year":"1991","journal-title":"Pharm Res"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916317981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916317981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T19:50:40Z","timestamp":1550778640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916317981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0022354916317981"],"URL":"https:\/\/doi.org\/10.1002\/jps.20334","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}